jueves, 5 de agosto de 2010

End stage renal disease (ESRD) - Centers for Medicare & Medicaid Services


NQMC has a New Look!
Welcome to the newly redesigned NQMC Web site! NQMC now offers updated design elements, a new measure summary display, enhanced searching, and easier access to all content. You may notice that some features are not yet fully functional. Please be assured that we are working to complete them. We hope you will be pleased with what you see and that the redesign will make your NQMC experience more productive and enjoyable.

Measure Summaries
Centers for Medicare & Medicaid Services


► 1. End stage renal disease (ESRD): percentage of adult (greater than or equal to 18 years old) hemodialysis and peritoneal dialysis patients, with ESRD greater than or equal to 3 months, who had received ESA therapy at any time during a 3 month study period AND who had Hb values reported for at least 2 of the 3 study months AND have achieved a mean hemoglobin of 10.0-12.0 g/dL for the 3 month study period.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15156


► 2. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) hemodialysis and peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb less than 11.0 g/dL in at least one month of the study period for whom serum ferritin concentration AND either percent transferrin saturation or reticulocyte Hb content (CHr) are measured at least once during the study period for in-center hemodialysis patients, and at least twice during the study period for peritoneal dialysis patients and home hemodialysis patients.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15158


► 3. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) hemodialysis and peritoneal dialysis patients, with ESRD greater than or equal to 3 months and who had Hb values reported for at least 2 of the 3 study months, who have a mean Hb less than 10.0 g/dL for a 3 month study period, irrespective of ESA use. http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15157


► 4. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) in-center hemodialysis patients in the sample for analyses for whom delivered hemodialysis dose was calculated using UKM or Daugirdas II during the study period and for whom the frequency of hemodialysis per week is specified.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15160


► 5. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) patients in the sample for analysis who have been on hemodialysis for 6 months or more and dialyzing thrice weekly whose average delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the study period.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15161


► 6. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) patients in the sample for analysis who have been on hemodialysis for 90 day or more and dialyzing thrice weekly, and have a residual renal function (if measured in the last three months) less than 2 ml/min/1.73m2, whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the reporting period.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15162


► 7. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis and hemodialysis patients included in the sample for analysis with serum calcium measured at least once within a month.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15166


► 8. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis and hemodialysis patients included in the sample for analysis with serum phosphorus measured at least once within a month.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15167


► 9. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis patients whose delivered peritoneal dialysis dose was a weekly Kt/V urea of at least 1.7 (dialytic + residual) during the four month study period.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15165


► 10. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis patients with total solute clearance for urea (endogenous residual renal urea clearance & dialytic) measured at least once in a four month time period. http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15163


► 11. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis patients with weekly Kt/V urea (endogenous residual renal urea clearance & dialytic) calculated in a standard way. http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15164


► 12. End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) hemodialysis patients in the sample for analyses with documented monthly adequacy measurements (spKt/V) or its components in the calendar month.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15159


► 13. End stage renal disease (ESRD): percentage of eligible Medicare hemodialysis patients at the facility during the calendar year with a median URR value of 65% or higher.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15146


► 14. End stage renal disease (ESRD): percentage of hemodialysis and peritoneal dialysis patients, with ESRD greater than or equal to 3 months, who have a mean hemoglobin greater than 12 g/dL for a 12 month reporting period, treated with ESA.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15148


► 15. End stage renal disease (ESRD): percentage of hemodialysis and peritoneal dialysis patients, with ESRD greater than or equal to 3 months, who have a mean hemoglobin less than 10 g/dL for a 12 month reporting period, treated with ESA.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15147


► 16. End stage renal disease (ESRD): percentage of patients on maintenance hemodialysis during the last hemodialysis treatment of the month using an autogenous AV fistula with two needles.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15168


► 17. End stage renal disease (ESRD): percentage of patients who are dialyzed with a chronic catheter (90 days or more) prior to the last hemodialysis session during the study period.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15169


► 18. End stage renal disease (ESRD): risk-adjusted standardized mortality ratio for dialysis facility patients.
http://qualitymeasures.ahrq.gov/content.aspx?f=rss&id=15149

No hay comentarios: